Literature DB >> 35024923

Modified Frailty Index to Assess Risk in Elderly Patients Undergoing Distal Pancreatectomy: A Retrospective Single-Center Study.

Salvatore Paiella1, Matteo De Pastena1, Alessandro Esposito2,3, Erica Secchettin1, Luca Casetti1, Giuseppe Malleo1, Greta Montagnini1, Elisa Bannone1, Giacomo Deiro1, Beatrice Bampa1, Marco Ramera1, Luca Landoni1, Alberto Balduzzi1, Claudio Bassi1, Roberto Salvia1.   

Abstract

BACKGROUND: To compare the postoperative course of elderly patients (≥70 years) submitted to minimally invasive (MIDP) versus open distal pancreatectomy (ODP) and to evaluate if the modified Frailty Index (mFI) predicts the surgical course of elderly patients submitted to DP.
METHODS: Data of patients aged ≥70 who underwent DP at a single institution between March 2011 and December 2019 were retrospectively retrieved. A 2:1 propensity score matching (PSM) was used to correct for differences in baseline characteristics. Then, postoperative complications were compared between the two groups (MIDP vs. ODP). Additionally, the entire cohort of DP elderly patients was stratified according to the mFI into three groups: non-frail (mFI = 0), mildly frail (mFI = 1/2), or severely frail (mFI = 3) and then compared.
RESULTS: A total of 204 patients were analyzed. After PSM, 40 MIDP and 80 ODP patients were identified. The complications considered stratified homogenously between the two groups, with no statistically significant differences. The severity of the postoperative course increased as mFI did among the three groups regarding any complication (p = 0.022), abdominal collection (p = 0.014), pulmonary complication (p = 0.001), postoperative confusion (p = 0.047), Clavien-Dindo severity ≥3 events (p = 0.036), and length of stay (p = 0.018).
CONCLUSIONS: Elderly patients can be safely submitted to MIDP. The mFI identifies frail elderly patients more prone to develop surgical and non-surgical complications after DP.
© 2022. The Author(s).

Entities:  

Mesh:

Year:  2022        PMID: 35024923      PMCID: PMC8885554          DOI: 10.1007/s00268-021-06436-2

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


Introduction

Minimally invasive distal pancreatectomy (MIDP) is gaining favor over open distal pancreatectomy (ODP) to treat the pancreas' body-tail neoplasms [1]. An international cohort study showed less major morbidity after MIDP, with predicted better outcomes as the conversion rate decreases following the implementation of the technique [2, 3]. Thanks to intervention in health, political, and socioeconomic aspects, lifespan, and healthspan are expected to increase in the next decades [4, 5], at least in developed countries. This scenario and the incidence of pancreatic tumors that increase with age–with a mean age of 70 years [5]—are responsible for the frequent facing with elderly patients by pancreatic surgeons. Current literature reports controversial results regarding the impact of advanced age on surgical outcomes after pancreatic surgery. In 2012, a meta-analysis reported that elderly patients experience higher rates of postoperative complications and mortality [6]. Other manuscripts, afterward, found that pancreatic surgery has similar safety and efficacy profiles in elderly versus non-elderly [7-10]. Regarding minimally invasive pancreaticoduodenectomy, data analysis on 1768 elderly patients submitted to laparoscopic versus open pancreaticoduodenectomy from the United States National Cancer Dabatase showed that minimally invasive cases experience lower mortality rates [11]. Few manuscripts have compared MIDP versus ODP in elderly patients. In particular, four retrospective, non-case-matched studies, enrolling a total of 248 patients, reported that MIDP has the same safety profile that ODP in elderly patients [12-14] and that some postoperative outcomes, such as confusion, length of stay, and intraoperative blood loss, are even better for MIDP [15]. Certainly, there is a proper patient selection beyond these surgical cohorts, so maybe the fittest ones were chosen. A recent meta-analysis pooled the results of these studies and confirmed the conclusions, indicating not only that MIDP is not contraindicated in the elderly but even that some postoperative outcomes are better in this subset of patients [16]. Not all elderly patients are the same, and to offer the same surgical approach to each one would be wrong. In particular, the selection of patients is of utmost importance to optimize surgical and oncological outcomes. Several indexes have been elaborated to predict poor postoperative outcomes in elderly patients undergoing pancreatectomy. The Frailty Index [17, 18], and its simplified form, the modified Frailty Index (mFI) [19] proved to predict major complications and mortality after pancreatic surgery effectively [20, 21]. Of note, it seems that frail patients (mFI ≥1) benefit from MIDP, experiencing less severe complications than ODP patients [22]. This study aimed to compare surgical outcomes between MIDP and ODP in elderly patients using propensity-score matching analysis. Secondarily, the efficacy of mFI in predicting postoperative outcomes of DP elderly patients was evaluated.

Methods

Study population

The index population for this study was obtained from the electronic Institutional prospectively maintained database of patients submitted to pancreatic resection at the General and Pancreatic Surgery Unit of the Pancreas Institute of the University of Verona, Verona, Italy. The database was queried for patients ≥70 years of age submitted to MIDP (index population), either laparoscopic and robot-assisted, with or without splenectomy, for any disease from March 2011 to December 2019. The database was then queried for patients ≥70 years who underwent ODP (control group) during the same period.

Data collected

Demographic, clinical, surgical, pathological, and postoperative data were extracted. Demographic and clinical variables included age, gender, smoking habit, body mass index (BMI), albumin, hemoglobin, and leukocyte values, presence of diabetes or other relevant comorbidities, American Society of Anesthesiologist Physical Status Classification System (ASA) score, Charlson Age Comorbidity index (CACI) [23]. When the final diagnosis was of malignancy, Ca 19–9 values and neoadjuvant therapy were added. According to the mFI, patients were stratified into non-frail (mFI = 0), mildly frail (mFI = 1–2), or severely-frail (mFI > 2), as proposed by Konstantinidis et al. [22]. This stratification was applied to the whole cohort of patients ≥70 years who underwent distal pancreatectomy, and matching was not used due to the small sample size of the MIDP group. Intraoperative variables included intraoperative blood loss (mL), duration of surgery (min), additional resections (yes/no), conversion to ODP, level of pancreatic transection (pancreatic neck/ gastroduodenal artery level/left aortic border), transection technique (stapler/ultrasonic device/ handsewn), splenic preservation. Ninety-day postoperative surgical data included pancreatic fistula (POPF) [24], delayed gastric emptying (DGE) [25], post-pancreatectomy hemorrhage (PPH) [26], infected abdominal collections treated with percutaneous drainage or antibiotic therapy, chyle leak [27], surgical site infections (SSI), pulmonary or cardiologic complications, and postoperative confusion. Postoperative pathologic data included final diagnosis, tumor diameter, lymph nodes harvested, lymph node status and the number of metastatic nodes (if any), and R-status.

Surgical procedures

For the description of the Institutional laparoscopic and robot-assisted techniques adopted, previously published material can be considered [28-30]. The decision to submit patients to MIDP and the choice of the laparoscopic or the robot-assisted approach was mostly made on a collegial basis at a dedicated preoperative surgical meeting [31]. The level of transection was made based on the presumed diagnosis (at the pancreatic neck for malignant or intermediate-malignant lesion vs. at the projection of the left border of the aorta for benign lesions, when tumor dimensions allowed it). Regarding the technique of transection, two devices were adopted in the vast majority of cases; the triple row stapler reinforced with a PGA felt (NEOVEIL Endo GIA Reinforced Reload with Tri-Staple® Technology 60 mm, Covidien, North Haven, CT, USA), or an ultrasonic scalpel [32, 33]. Typically, for ODP, two Penrose-type capillary drains were placed at the end of the surgery, one close to the pancreatic stump, the other in the splenic fossa. After MIDP, one Penrose-type capillary drain was placed, close to the pancreatic stump and passing through the splenic fossa. When the patient was enrolled in the DIPLOMA trial (MIDP vs. ODP in patients with pancreatic cancer, #ISRCTN44897265), two drains were placed, one to the left into the splenic fossa and one to the right close to the pancreatic stump. Early drains removal was frequently performed based on the quality and quantity of the output, its richness in amylase, and the occurrence of postoperative acute pancreatitis [34]. Generally, in the presence of a non-amylase-rich fluid (e.g., ≤ 2000 U/L) and the absence of a sinister appearance or postoperative acute pancreatitis, the removal was performed on postoperative day three.

Statistical analysis and case-matching

According to the normality tests, values were expressed as median and interquartile range, mean and standard deviation (SD), or percentage. Student’s t-test, Mann- Whitney U-test, Kruskal–Wallis test, and χ2 test were used as appropriate. A PSM analysis was performed using the preliminary univariate analysis on the entire cohort. The not balanced variables identified were chosen to compare the MIDP (index) group and the ODP (control) group. The MIDP elderly patients were randomly matched with ODP elderly patients according to a 1:2 matching, with a 0.1 caliper and an average treatment effect (ATE), by the approach (MIDP vs. ODP) as the independent variable. Variables considered for propensity score estimation included: age, CACI, splenectomy, additional resections, pancreatic transection level, management of the pancreatic stump, and presence of malignancy at the final pathology. Balance on covariates between MIDP and ODP groups was assessed and reported using absolute standardized differences (ASD) [35]. An ASD value <0.2 indicates a small difference between the two groups, identifying an excellent balance. An ASD value between 0.2 and 0.5 shows a difference, implying a good balance. An ASD value between 0.5 and 0.8 indicates a high difference, meaning sub-optimal balance. An ASD value > 0.8 resulted in a remarkable difference, suggesting a poor balance between the two groups (Supplementary Fig. 1) [36]. Statistical analyses were performed using SPSS software ver. 22 (IBM, Chicago, IL, United States) and R software (R Foundation for Statistical Computing, Vienna, Austria).

Results

A total of 204 patients aged ≥70 years was submitted to distal pancreatectomy during the study period. Forty-six patients were candidates to receive MIDP, and four (7.7%) were converted to open surgery. The preoperative, intraoperative, and pathological data are shown in Table 1. The two groups resulted imbalanced in age, CACI, splenectomy, additional resections, pancreatic transection level, management of the pancreatic stump, and presence of malignancy at the final pathology (p < 0.05).
Table 1

Preoperative, intraoperative, and pathological data

Study Population N° = 204
Total n° (%)Open DP 162 (79%)MI-DP 42 (21%)p-value
Preoperative data
Age (years, DS)74 ± 475 ± 474 ± 40.032
Sex (Female)108 (53%)87 (54%)21 (50%)0.399
BMI (Kg/m2, DS)25 ± 425 ± 425 ± 40.567
Previous abdominal surgery114 (56%)92 (57%)22 (52%)0.351
ASA score > III61 (30%)53 (33%)8 (19%)0.059
Charlson Age > 478 (38%)68 (42%)10 (24%)0.022
Neoadjuvant therapy30 (15%)25 (15%)5 (12%)0.383
Frailty index > 0150 (74%)120 (74%)30 (71%)0.433
Intraoperative data
Spleen preserving11 (5%)5 (3%)6 (14%)0.011
Additional resections68 (33%)59 (36%)9 (21%)0.046
Vascular resections31 (15%)28 (17%)3 (7%)0.076
Transection level <0.001
Pancreatic neck165 (81%)130 (80%)35 (83%)
GDA level29 (14%)29 (18%)0 (0%)
Left aortic border10 (5%)3 (2%)7 (17%)
Management Stump0.001
Stapler85 (44%)67 (44%)18 (43%)
Ultrasonic scalpel64 (33%)42 (28%)22 (52%)
Handsewn45 (23%)43 (28%)2 (5%)
Duration of Surgery (minutes, DS)260 ± 93258 ± 88267 ± 950.175
EBL (cc, IQR)200 [100–400]250 [100–400]200 [150–300]0.998
Pathological data
Final Pathology, No. (%) <0.001
PDAC119 (58%)102 (63%)17 (41%)
pNET33 (16%)16 (10%)17 (40%)
IPMN27 (13%)23 (14%)4 (10%)
MCN/SCN11 (6%)8 (5%)3 (7%)
Other14 (7%)13 (8%)1 (2%)
Tumor Size (mm, IQR)29 [20–45]30 [20–45]26 [18–40]0.372
Harvest Lymph nodes (IQR)28 [19–37]32 [23–40]24 [13–33]0.001
R0 Status159 (81%)125 (80%)34 (81%)0.300

Bold values indicate statistical significance at the p < 0.05 level

BMI Body mass index; ASA American society of Anesthesiology; EBL Estimated blood loss; PDAC Pancreatic ductal adenocarcinoma; pNET pancreatic neuroendocrine tumor; IPMN Intraductal pancreatic mucinous neoplasm; MCN Mucinous cystic neoplasm; SCN Serous cystic neoplasm

Preoperative, intraoperative, and pathological data Bold values indicate statistical significance at the p < 0.05 level BMI Body mass index; ASA American society of Anesthesiology; EBL Estimated blood loss; PDAC Pancreatic ductal adenocarcinoma; pNET pancreatic neuroendocrine tumor; IPMN Intraductal pancreatic mucinous neoplasm; MCN Mucinous cystic neoplasm; SCN Serous cystic neoplasm The postoperative outcomes of the series are outlined in Table 2. The postoperative clinical course of the entire cohort was comparable (p > 0.05). Notably, the ODP group had a higher mean length of stay than the MIDP (15 vs. 10 days, respectively, p = 0.042).
Table 2

Postoperative data

Study Population N° = 204
Total n° (%)Open DP 162 (79%)MI-DP 42 (21%)p-value
Any complications118 (58%)93 (57%)25 (60%)0.473
POPF38 (19%)28 (17%)10 (24%)0.204
Abdominal collections70 (34%)53 (33%)17 (41%)0.222
DGE5 (3%)5 (3%)0 (0%)0.312
PPH25 (12%)20 (12%)5 (12%)0.589
SSI18 (9%)15 (9%)3 (7%)0.470
Pulmonary complications53 (26%)43 (27%)10 (24%)0.443
Cardiovascular complications18 (9%)17 (11%)1 (2%)0.080
Postoperative Confusion8 (4%)8 (5%)0 (0%)0.152
ICU Admission17 (8%)15 (9%)2 (5%)0.274
Clavien-Dindo > 327 (13%)22 (14%)5 (12%)0.503
Length of Stay (days, DS)13 ± 615 ± 610 ± 70.042
Reoperations11 (5%)8 (5%)3 (7%)0.403
Readmissions14 (7%)10 (6%)4 (9%)0.323
Mortality2 (1%)2 (1%)0 (0%)0.628

Bold value indicates statistical significance at the p < 0.05 level

POPF Postoperative pancreatic fistula; DGE Delayed gastric empty; PPH Post pancreatectomy hemorrhage; ICU Intensive care unit

Postoperative data Bold value indicates statistical significance at the p < 0.05 level POPF Postoperative pancreatic fistula; DGE Delayed gastric empty; PPH Post pancreatectomy hemorrhage; ICU Intensive care unit After matching, 40 and 80 patients constituted the MIDP group and ODP group, respectively.

MIDP versus ODP after matching: baseline, surgical, pathology, and postoperative results

No differences were found in the patients’ baseline characteristics between MIDP and ODP groups after propensity score weighting was found (Table 3). The pancreatic transection was more frequently on the left aortic border in the MIDP group (p = 0.005).
Table 3

Preoperative, intraoperative, and pathological data after propensity score matching

Study Population N° = 120
Total n° (%)Open DP 80 (67%)MI-DP 40 (33%)p-value
Preoperative
Age (years, DS)74 ± 374 ± 473 ± 30.127
Sex (Female)64 (53%)43 (53%)21 (54%)0.547
BMI (Kg/m2, DS)25 ± 425 ± 425 ± 40.720
Previous abdominal surgery65 (54%)45 (55%)20 (51%)0.403
ASA score > III29 (24%)22 (27%)7 (18%)0.191
Charlson Age > 434 (28%)26 (32%)8 (21%)0.134
Neoadjuvant therapy19 (16%)14 (17%)5 (13%)0.367
Frailty index > 087 (73%)59 (73%)28 (72%)0.534
Intraoperative
Spleen preserving11 (9%)5 (6%)6 (15%)0.099
Additional resection30 (25%)23 (28%)7 (18%)0.156
Vascular resection15 (13%)12 (15%)3 (8%)0.212
Transection level0.005
Pancreatic neck111 (93%)78 (98%)33 (82%)
Left aortic border9 (7%)2 (2%)7 (18%)
Management Stump0.099
Stapler64 (53%)47 (58%)17 (44%)
Ultrasonic scalpel56 (47%)33 (42%)23 (56%)
Duration of Surgery (minutes, DS)261 ± 92252 ± 86261 ± 840.166
EBL (cc, IQR)250 [100–400]265 [100–400]200 [150–300]0.101
Pathological
Final Pathology, No. (%)0.071
PDAC60 (50%)43 (53%)16 (43%)
pNET25 (21%)9 (12%)16 (40%)
IPMN15 (13%)12 (15%)3 (7%)
MCN/SCN8 (7%)5 (6%)3 (7%)
Other12 (9%)11 (14%)1 (3%)
Tumor Size (mm, IQR)27 [20–40]30 [20–40]24 [18–33]0.238
Harvest Lymph nodes (IQR)25 [16–34]26 [19–39]25 [13–32]0.054
R0 Status103 (86%)70 (88%)33 (83%)0.473

Bold value indicates statistical significance at the p < 0.05 level

BMI Body mass index; ASA American society of Anesthesiology; EBL Estimated blood loss; PDAC Pancreatic ductal adenocarcinoma; pNET pancreatic neuroendocrine tumor; IPMN Intraductal pancreatic mucinous neoplasm; MCN Mucinous cystic neoplasm; SCN Serous cystic neoplasm

Preoperative, intraoperative, and pathological data after propensity score matching Bold value indicates statistical significance at the p < 0.05 level BMI Body mass index; ASA American society of Anesthesiology; EBL Estimated blood loss; PDAC Pancreatic ductal adenocarcinoma; pNET pancreatic neuroendocrine tumor; IPMN Intraductal pancreatic mucinous neoplasm; MCN Mucinous cystic neoplasm; SCN Serous cystic neoplasm None of the postoperative variables considered stratified differently from a statistical standpoint between the two groups (Table 4). Remarkably, the ODP group still had a higher mean length of stay than the MIDP (16 vs. 10 days, respectively, p = 0.046).
Table 4

Postoperative outcomes after propensity score matching

Study Population N° = 120
Total n° (%)Open DP 80 (67%)MI-DP 40 (33%)p-value
Any complications71 (59%)48 (59%)23 (59%)0.565
POPF25 (21%)16 (20%)9 (24%)0.396
Abdominal collections46 (38%)30 (37%)16 (41%)0.411
DGE4 (3%)4 (5%)0 (0%)0.203
PPH16 (13%)11 (14%)5 (13%)0.578
SSI11 (9%)8 (10%)3 (8%)0.493
Pulmonary complications29 (24%)20 (25%)9 (23%)0.519
Cardiovascular complications10 (8%)9 (11%)1 (3%)0.104
Postoperative Confusion3 (3%)3 (4%)0 (0%)0.304
ICU Admission8 (7%)6 (7%)2 (5%)0.486
Clavien-Dindo > 316 (13%)12 (15%)4 (10%)0.353
Length of Stay (days, DS)13 ± 1416 ± 2010 ± 70.046
Reoperations7 (6%)5 (6%)2 (5%)0.590
Readmissions10 (8%)6 (8%)4 (10%)0.425
Mortality1 (1%)1 (1%)0 (0%)0.672

Bold value indicates statistical significance at the p < 0.05 level

POPF Postoperative pancreatic fistula; DGE Delayed gastric empty; PPH Post pancreatectomy hemorrhage; ICU Intensive care unit

Postoperative outcomes after propensity score matching Bold value indicates statistical significance at the p < 0.05 level POPF Postoperative pancreatic fistula; DGE Delayed gastric empty; PPH Post pancreatectomy hemorrhage; ICU Intensive care unit

Baseline, surgical, and pathology results and postoperative outcome according to mFI

Among the baseline features, BMI and ASA score were higher in severely frail patients (p = 0.001 and p <  0.001, respectively), as shown in Table 5. Surgery’s duration increased as the severity of frailty did (p = 0.013). No differences were found in pathology data among the three groups.
Table 5

Stratification of the study population according to the modified Frailty Index

Study Population N° = 204
No Frail 54 (26%)Mildly Frail 125 (26%)Severely Frail 25 (74%)p-value
Preoperative data
Age (years, DS)75 ± 475 ± 475 ± 40.897
Sex (Female)33 (61%)65 (52%)10 (40%)0.205
BMI (Kg/m2, DS)23 ± 325 ± 426 ± 40.001
Previous abdominal surgery33 (61%)66 (53%)15 (60%)0.535
ASA score > III7 (13%)35 (28%)19 (76%) <0.001
Neoadjuvant therapy5 (9%)19 (15%)6 (24%)0.221
Intraoperative data
Spleen preserving3 (6%)7 (6%)1 (4%)0.947
Additional resections17 (32%)38 (30%)13 (52%)0.106
Vascular resections9 (17%)17 (14%)5 (20%)0.675
Transection level0.387
Pancreatic neck44 (82%)101 (81%)20 (80%)
GDA level5 (9%)20 (16%)4 (16%)
Left aortic border5 (9%)4 (3%)1 (4%)
Management Stump0.924
Stapler21 (40%)52 (45%)12 (50%)
Ultrasonic scalpel18 (34%)39 (33%)7 (29%)
Handsewn14 (26%)26 (22%)5 (21%)
Duration of Surgery (minutes, DS)224 ± 64271 ± 93297 ± 1010.013
EBL (cc, IQR)200 [100–350]250 [200–320]260 [220–355]0.565
Pathological data
Final Pathology, No. (%)0.414
PDAC31 (58%)71 (57%)17 (68%)
pNET12 (22%)17 (14%)4 (16%)
IPMN5 (9%)19 (15%)3 (12%)
MCN/SCN1 (2%)10 (8%)0 (0%)
Other5 (9%)8 (6%)1 (4%)
Tumor Size (mm, IQR)30 [22–50]25 [20–40]28 [20–45]0.799

Bold values indicate statistical significance at the p < 0.05 level

BMI Body mass index; ASA American society of Anesthesiology; EBL Estimated blood loss; PDAC Pancreatic ductal adenocarcinoma; pNET pancreatic neuroendocrine tumor; IPMN Intraductal pancreatic mucinous neoplasm; MCN Mucinous cystic neoplasm; SCN Serous cystic neoplasm

Stratification of the study population according to the modified Frailty Index Bold values indicate statistical significance at the p < 0.05 level BMI Body mass index; ASA American society of Anesthesiology; EBL Estimated blood loss; PDAC Pancreatic ductal adenocarcinoma; pNET pancreatic neuroendocrine tumor; IPMN Intraductal pancreatic mucinous neoplasm; MCN Mucinous cystic neoplasm; SCN Serous cystic neoplasm Increasing and statistically significant rates of many complications were found among the three groups, where the severely frail patients worsen, compared to mildly frail and no frail ones (Table 6). In particular, this refers to any complication (76% vs. 60% vs. 44%, p = 0.022), abdominal collection (52% vs. 37% vs. 20%, p = 0.014), pulmonary complication (54% vs. 24% vs. 17%, p = 0.001), postoperative confusion (12% vs. 3% vs. 2%, p = 0.047), and Clavien-Dindo severity ≥3 events (24% vs. 14% vs. 6%, p = 0.036). The length of stay was significantly longer in severely frail patients (16 vs. 13 vs. 12 days, p = 0.018).
Table 6

Postoperative outcomes of the series stratified according to the modified Frailty Index

Study Population N° = 204
No Frailty 54 (26%)Mild Frailty 125 (26%)Severe Frailty 25 (74%)p-value
Any complications24 (44%)75 (60%)19 (76%)0.022
POPF7 (13%)27 (22%)4 (16%)0.824
Abdominal collections11 (20%)46 (37%)13 (52%)0.014
DGE0 (0%)4 (3%)1 (4%)0.387
PPH5 (9%)16 (13%)4 (16%)0.667
SSI5 (9%)10 (8%)3 (12%)0.806
Pulmonary complications9 (17%)30 (24%)14 (54%)0.001
Cardiovascular complications1 (2%)14 (11%)3 (12%)0.108
Postoperative Confusion1 (2%)4 (3%)3 (12%)0.047
ICU Admission2 (4%)12 (10%)3 (12%)0.327
Clavien-Dindo > 33 (6%)18 (14%)6 (24%)0.036
Length of Stay (days, DS)12 ± 613 ± 916 ± 120.018
Reoperations2 (4%)7 (6%)2 (8%)0.724
Readmissions4 (7%)7 (6%)3 (12%)0.512
Mortality0 (0%)2 (2%)0 (0%)0.525

Bold values indicate statistical significance at the p < 0.05 level

POPF Postoperative pancreatic fistula; DGE Delayed gastric empty; PPH Post pancreatectomy hemorrhage; ICU Intensive care unit

Postoperative outcomes of the series stratified according to the modified Frailty Index Bold values indicate statistical significance at the p < 0.05 level POPF Postoperative pancreatic fistula; DGE Delayed gastric empty; PPH Post pancreatectomy hemorrhage; ICU Intensive care unit

Discussion

Reduced functional reserve and stress response and high prevalence of comorbidities are typical features of the elderly. Thus, this population of patients may benefit the most from minimally invasive surgery. However, only four reports compared surgical outcomes of MIDP versus ODP in elderly patients [12-15]. All studies concluded that MIDP is at least as safe as ODP. These results were pooled in a meta-analysis that reported an overall benefit for MIDP over ODP regarding length of stay and intraoperative blood loss [16]. The results of this study corroborate these previous findings, namely that MIDP in elderly patients can be safely performed, as no differences were found in terms of postoperative outcomes. In particular, major complications, surgical and non-surgical complications (e.g., cardiopulmonary events) occurred homogeneously between the index and control groups, and the length of stay was similar. It must be noted that this study's findings are the result of a careful selection of cases to treat with MIDP, deriving from proper preoperative evaluation and collegial discussion. Noteworthily, the duration of hospitalization of MIDP patients (median 8, IQR 7–12) was lower than the one institutionally reported for MIDP (10 days, IQR 6–10), deriving from a cohort of 103 patients with a mean age of 52 years [IQR 40–62]) [37]. This finding gain strength considering that all patients are discharged home in our institution rather than going to health care facilities. So, a patient goes home when the spouse or the relatives/caregivers (usually the children) are ready to accommodate him, which may take longer when the patient is elderly. Despite desirable, a preoperative geriatric assessment may not be feasible for each elder patient. Thus, the possibility to use the mFI to identify elderly patients at higher risk of postoperative complications is an interesting opportunity. After applying the mFI to the whole cohort of patients ≥70 years submitted to DP, the baseline features analysis showed that BMI was proportionally higher for mildly and severely frail patients than non-frail ones. They were also more frequently classified as ASA ≥3, probably due to more systemic diseases (e.g., diabetes, hypertension, cardiovascular problems). The duration of surgery increased proportionally to the grade of frailty. We do not have an explanation for this. This may be due to the surgeon’s attitude toward performing a more precise and safe surgery in the presence of a severely frail patient, which carries serious comorbidities. However, this is just speculation. As already reported [22, 38], the mFI predicted some postoperative complications and, in general, a worse postoperative course, as demonstrated by a longer length of stay. In detail, higher rates of any complication, abdominal collection, and Clavien-Dindo ≥3 complications were found in mild and severely frail patients, compared to non-frail ones. Noteworthily, the mFI also predicted non-surgical postoperative complications, such as postoperative confusion and pulmonary complications. These results show that surgical and non-surgical risk prediction may be obtained using an easy tool such as the mFI. It must be noted that, interestingly, after DP, some postoperative complications, such as pancreatic fistula, post-pancreatectomy hemorrhage, and the reoperation rate, are not superior in frail patients. We believe that they are hardly favored by the cardiovascular comorbidities and the poor functional reserve that may be present in a frail patient. Rather, they are the result of properly pancreas- and surgery-specific factors (e.g., pancreatic texture, transection technique, level of transection, and drain management policy). In general, our findings demonstrate that MIDP is not inferior to ODP in selected elderly patients, and that fragile elderly patients are at higher risk for postoperative complications after DP, with a proportionate increase. In the absence of a geriatric assessment, the application of the mFI may be useful to identify patients to whom dedicate tailored perioperative management to improve the postoperative outcome (e.g., nutritional assessment and intervention, pre-habilitation, routine access to intensive care unit after surgery). We deliberately choose not to include the mFI among the crucial variables in the PSM since previous literature on mFI and distal pancreatectomy was not robust enough. The present results give consistency to mFI as a variable to include in the baseline assessment of elderly patients receiving DP. This manuscript's strength is that for the first time, the comparison between MIDP and ODP in elderly patients was performed through a propensity score matching to reduce the selection bias. This study is also the first to apply the mFI to a single-center, homogeneous cohort of elderly patients undergoing DP (the report by Konstantinidis et al. [22] is a registry-based study). Some limitations may flaw the results and the considerations: (i) the sample size of elderly who underwent MIDP is small; (ii) a selection bias (the percentage of elderly submitted to MIDP is approximately only 20 percent of the total of elderly underwent DP during the study period). To conclude, MIDP in elderly patients seems to be safe in experienced hands and high-volume centers. Fragile (mFI > 0) elderly patients undergoing DP are more prone to experience postoperative complications, longer hospitalization, and worse postoperative course as the mFI increases. Age per sé is not an expression of poor functional reserve or difficult recovery after surgery. Age and frailty, instead, can be so. Below is the link to the electronic supplementary material. Imbalances between MIDP and ODP groups before and after propensity score weighting. This figure represents the absolute standardized differences, showing imbalances of patients’ baseline characteristics between MIDP and ODP groups before and after propensity score weighting. A standardized difference <0.1 (<10%) is considered ideal (excellent covariate balance), <0.2 (20%) is considered acceptable. Red circle symbol: without weighting. Blue circle symbol: using the inverse of the propensity score as a weight (JPG 25 KB)
  36 in total

Review 1.  Reporting of covariate selection and balance assessment in propensity score analysis is suboptimal: a systematic review.

Authors:  M Sanni Ali; Rolf H H Groenwold; Svetlana V Belitser; Wiebe R Pestman; Arno W Hoes; Kit C B Roes; Anthonius de Boer; Olaf H Klungel
Journal:  J Clin Epidemiol       Date:  2014-11-26       Impact factor: 6.437

2.  Surgical outcomes of laparoscopic distal pancreatectomy in elderly and octogenarian patients: a single-center, comparative study.

Authors:  Ke Chen; Yu Pan; Yi-Ping Mou; Jia-Fei Yan; Ren-Chao Zhang; Miao-Zun Zhang; Jia-Yu Zhou; Xian-Fa Wang; Hendi Maher; Qi-Long Chen
Journal:  Surg Endosc       Date:  2018-10-25       Impact factor: 4.584

3.  Minimally invasive distal pancreatectomy: greatest benefit for the frail.

Authors:  Ioannis T Konstantinidis; Aaron Lewis; Byrne Lee; Susanne G Warner; Yanghee Woo; Gagandeep Singh; Yuman Fong; Laleh G Melstrom
Journal:  Surg Endosc       Date:  2017-05-10       Impact factor: 4.584

4.  Accumulating deficits model of frailty and postoperative mortality and morbidity: its application to a national database.

Authors:  Vic Velanovich; Heath Antoine; Andrew Swartz; David Peters; Ilan Rubinfeld
Journal:  J Surg Res       Date:  2013-02-01       Impact factor: 2.192

5.  A prospective non-randomised single-center study comparing laparoscopic and robotic distal pancreatectomy.

Authors:  Giovanni Butturini; Isacco Damoli; Lorenzo Crepaz; Giuseppe Malleo; Giovanni Marchegiani; Despoina Daskalaki; Alessandro Esposito; Sara Cingarlini; Roberto Salvia; Claudio Bassi
Journal:  Surg Endosc       Date:  2015-01-01       Impact factor: 4.584

6.  A randomized controlled trial of stapled versus ultrasonic transection in distal pancreatectomy.

Authors:  Luca Landoni; Matteo De Pastena; Giovanni Butturini; Roberto Salvia; Martina Fontana; Giuseppe Malleo; Alessandro Esposito; Luca Casetti; Giovanni Marchegiani; Massimiliano Tuveri; Salvatore Paiella; Antonio Pea; Marco Ramera; Alex Borin; Alessandro Giardino; Isabella Frigerio; Roberto Girelli; Claudio Bassi
Journal:  Surg Endosc       Date:  2021-09-13       Impact factor: 3.453

Review 7.  Definition and classification of chyle leak after pancreatic operation: A consensus statement by the International Study Group on Pancreatic Surgery.

Authors:  Marc G Besselink; L Bengt van Rijssen; Claudio Bassi; Christos Dervenis; Marco Montorsi; Mustapha Adham; Horacio J Asbun; Maximillian Bockhorn; Oliver Strobel; Markus W Büchler; Olivier R Busch; Richard M Charnley; Kevin C Conlon; Laureano Fernández-Cruz; Abe Fingerhut; Helmut Friess; Jakob R Izbicki; Keith D Lillemoe; John P Neoptolemos; Michael G Sarr; Shailesh V Shrikhande; Robert Sitarz; Charles M Vollmer; Charles J Yeo; Werner Hartwig; Christopher L Wolfgang; Dirk J Gouma
Journal:  Surgery       Date:  2016-09-28       Impact factor: 3.982

8.  Cost-effectiveness and quality of life analysis of laparoscopic and robotic distal pancreatectomy: a propensity score-matched study.

Authors:  Matteo De Pastena; Alessandro Esposito; Salvatore Paiella; Niccolò Surci; Greta Montagnini; Giovanni Marchegiani; Giuseppe Malleo; Erica Secchettin; Luca Casetti; Claudio Ricci; Luca Landoni; Chiara Bovo; Claudio Bassi; Roberto Salvia
Journal:  Surg Endosc       Date:  2020-04-02       Impact factor: 4.584

9.  Implementation of a strategic preoperative surgical meeting to improve the level of care at a high-volume pancreatic center: a before-after analysis of 1000 consecutive cases.

Authors:  Niccolò Surci; Marco Ramera; Alex Borin; Giovanni Marchegiani; Roberto Salvia; Claudio Bassi
Journal:  Updates Surg       Date:  2020-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.